BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16645899)

  • 1. Gastric H,K-ATPase as a drug target.
    Shin JM; Sachs G
    Dig Dis Sci; 2006 May; 51(5):823-33. PubMed ID: 16645899
    [No Abstract]   [Full Text] [Related]  

  • 2. Acid secretion and Helicobacter pylori.
    Sachs G; Meyer-Rosberg K; Scott DR; Melchers K; Shin J; Besancon M
    Digestion; 1997; 58 Suppl 1():8-13. PubMed ID: 9225081
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton pump inhibitors and acid-related diseases.
    Sachs G
    Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract]   [Full Text] [Related]  

  • 5. Review article: the control of gastric acid and Helicobacter pylori eradication.
    Sachs G; Shin JM; Munson K; Vagin O; Lambrecht N; Scott DR; Weeks DL; Melchers K
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1383-401. PubMed ID: 11069309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors.
    Katelaris PH
    Med J Aust; 1998 Aug; 169(4):208-11. PubMed ID: 9734580
    [No Abstract]   [Full Text] [Related]  

  • 7. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of modern anti-ulcer drugs.
    Garner A
    Br J Clin Pract Suppl; 1994; 75():1-5; discussion 6-8. PubMed ID: 7914740
    [No Abstract]   [Full Text] [Related]  

  • 10. Practice guidelines for treatment of peptic ulcer disease.
    Olson CA
    JAMA; 1996 Oct; 276(14):1135-6; author reply 1136-7. PubMed ID: 8827958
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
    Gisbert JP
    Gastroenterol Hepatol; 2005 Nov; 28(9):567-75. PubMed ID: 16277966
    [No Abstract]   [Full Text] [Related]  

  • 12. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
    Besancon M; Simon A; Sachs G; Shin JM
    J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms in therapy of acid-related diseases.
    Shin JM; Vagin O; Munson K; Kidd M; Modlin IM; Sachs G
    Cell Mol Life Sci; 2008 Jan; 65(2):264-81. PubMed ID: 17928953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice guidelines for treatment of peptic ulcer disease.
    Fennerty MB
    JAMA; 1996 Oct; 276(14):1135; author reply 1136-7. PubMed ID: 8827957
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion and gastroduodenal ulcers in rats.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    Methods Find Exp Clin Pharmacol; 1999 Mar; 21(2):115-22. PubMed ID: 10327392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of Helicobacter pylori and dosages of esomeprazole.
    Manes G; Ferrara EC; Porro GB
    Am J Gastroenterol; 2006 Jun; 101(6):1398-9; author reply 1399-400. PubMed ID: 16771971
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of Syrian hamster gastric mucosal H+,K+-ATPase.
    Chatterjee PK; Das PK
    Mol Cell Biochem; 1995 Jul; 148(2):95-103. PubMed ID: 8594424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible inhibitors of the gastric (H+/K+)-ATPase as both potential therapeutic agents and probes of pump function.
    Pope AJ; Sachs G
    Biochem Soc Trans; 1992 Aug; 20(3):566-72. PubMed ID: 1330781
    [No Abstract]   [Full Text] [Related]  

  • 20. The H+/K+-ATPase inhibitory activities of Trametenolic acid B from Trametes lactinea (Berk.) Pat, and its effects on gastric cancer cells.
    Zhang Q; Huang N; Wang J; Luo H; He H; Ding M; Deng WQ; Zou K
    Fitoterapia; 2013 Sep; 89():210-7. PubMed ID: 23742858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.